BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $622,492 | -20.8% | 15,347 | -0.5% | 0.17% | -24.8% |
| Q4 2022 | $785,877 | -7.4% | 15,418 | -2.1% | 0.22% | -15.3% |
| Q3 2022 | $849,000 | -16.9% | 15,755 | -1.0% | 0.26% | -13.2% |
| Q2 2022 | $1,022,000 | -17.4% | 15,912 | -0.3% | 0.30% | -3.2% |
| Q1 2022 | $1,238,000 | -11.8% | 15,960 | -2.3% | 0.31% | -9.6% |
| Q4 2021 | $1,403,000 | +1.9% | 16,340 | -4.5% | 0.34% | -5.7% |
| Q3 2021 | $1,377,000 | -2.5% | 17,114 | -2.5% | 0.37% | -2.4% |
| Q2 2021 | $1,412,000 | -5.6% | 17,545 | -1.1% | 0.38% | -12.8% |
| Q1 2021 | $1,496,000 | +4.2% | 17,740 | -0.9% | 0.43% | -2.9% |
| Q4 2020 | $1,436,000 | +1.3% | 17,898 | +1.6% | 0.44% | -13.6% |
| Q3 2020 | $1,417,000 | -6.5% | 17,615 | +0.1% | 0.51% | -14.2% |
| Q2 2020 | $1,515,000 | +6.3% | 17,599 | +0.3% | 0.60% | -11.8% |
| Q1 2020 | $1,425,000 | -5.8% | 17,551 | -3.0% | 0.68% | +18.3% |
| Q4 2019 | $1,513,000 | -4.2% | 18,098 | +0.3% | 0.57% | -12.7% |
| Q3 2019 | $1,579,000 | +7.1% | 18,052 | +0.3% | 0.66% | +6.0% |
| Q2 2019 | $1,474,000 | -7.2% | 18,003 | -7.9% | 0.62% | -4.8% |
| Q1 2019 | $1,589,000 | +23.2% | 19,542 | -0.3% | 0.65% | +7.8% |
| Q4 2018 | $1,290,000 | -14.7% | 19,601 | -0.2% | 0.60% | -1.3% |
| Q3 2018 | $1,513,000 | +4.0% | 19,632 | -0.4% | 0.61% | -2.7% |
| Q2 2018 | $1,455,000 | +11.0% | 19,702 | -2.3% | 0.63% | +9.8% |
| Q1 2018 | $1,311,000 | -65.6% | 20,160 | -73.2% | 0.57% | -75.3% |
| Q4 2017 | $3,816,000 | +200.9% | 75,133 | +271.9% | 2.32% | +301.6% |
| Q3 2017 | $1,268,000 | +3.3% | 20,205 | -0.3% | 0.58% | -0.9% |
| Q2 2017 | $1,227,000 | +17.0% | 20,273 | +0.2% | 0.58% | +15.9% |
| Q1 2017 | $1,049,000 | +19.9% | 20,223 | +2.4% | 0.50% | +11.1% |
| Q4 2016 | $875,000 | -7.9% | 19,742 | -1.1% | 0.45% | -12.2% |
| Q3 2016 | $950,000 | +8.4% | 19,967 | +3.0% | 0.52% | +3.2% |
| Q2 2016 | $876,000 | +13.6% | 19,379 | +3.3% | 0.50% | +9.2% |
| Q1 2016 | $771,000 | +9.7% | 18,768 | +1.9% | 0.46% | +4.1% |
| Q4 2015 | $703,000 | +12.5% | 18,427 | -3.1% | 0.44% | +4.5% |
| Q3 2015 | $625,000 | -53.3% | 19,023 | -0.7% | 0.42% | -50.5% |
| Q2 2015 | $1,339,000 | +1.7% | 19,151 | -0.3% | 0.85% | +0.2% |
| Q1 2015 | $1,316,000 | -7.1% | 19,207 | -0.6% | 0.85% | -11.2% |
| Q4 2014 | $1,416,000 | +1.6% | 19,320 | -0.5% | 0.95% | -3.0% |
| Q3 2014 | $1,394,000 | -0.9% | 19,418 | -0.2% | 0.98% | -3.2% |
| Q2 2014 | $1,407,000 | -2.2% | 19,466 | -0.5% | 1.01% | -7.7% |
| Q1 2014 | $1,439,000 | +5.6% | 19,556 | -0.2% | 1.10% | +5.4% |
| Q4 2013 | $1,363,000 | – | 19,598 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |